X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CAPR

Closed

Capricor Therapeutics Inc

9.7
-0.2 (-2.01%)
Last Update: 01 Jul 2025 23:27:00
Yesterday: 9.93
Day's Range: 9.47 - 10.02
Send
When Written:
 
4.22
Capricor Therapeutics Inc is a biotechnology company that focuses on developing regenerative medicine and therapeutic products for the treatment of various diseases. The company's lead product candidate is CAP-1002, a cell-based therapy that is being developed for the treatment of Duchenne muscular dystrophy and other rare diseases. Capricor Therapeutics is also developing exosome-based therapeutics for the treatment of various diseases, including cardiovascular diseases, neurological disorders, and cancer. The company was founded in 2005 and is headquartered in Los Angeles, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.15
X